653 Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling

Autor: Doepner, M., Natale, C., Lee, I., Brathwaite, R., Venkat, S., Kim, S., Wei, Y., Vakoc, C., Katzenellenbogen, J., Katzenellenbogen, B., Feigin, M., Ridky, T.W.
Zdroj: In Journal of Investigative Dermatology August 2022 142(8) Supplement:S112-S112
Databáze: ScienceDirect